IN A006
Alternative Names: IN-A006Latest Information Update: 13 May 2022
Price :
$50 *
At a glance
- Originator HK inno.N
- Class Antineoplastics; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer
Most Recent Events
- 04 May 2022 Early research in Cancer in South Korea (unspecified route) prior to May 2022 (HK inno.N pipeline, May 2022)